We are live on ! Find out more
VarCov Co

VarCov Co Portfolio holdings

AUM $205M Turnover 78.57%
1-Year Est. Return 11.72%
This Fund
S&P 500
This Quarter Est. Return
-6.18%
1 Year Est. Return
+11.72%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$205M
AUM Growth
-$58.6M
Cap. Flow
-$43M
Cap. Flow %
-20.99%
Top 10 Hldgs %
11.64%
Holding
574
New
222
Increased
52
Reduced
71
Closed
229
Avg Time Held
0.1 years
Top 10 Avg Time Held
0 years
Top 20 Avg Time Held
0.1 years

Top Sells

Rank Stock Value
1
KMX icon
CarMax
KMX
+$3.97M
2
WMS icon
Advanced Drainage Systems
WMS
+$3.17M
3
UWMC icon
UWM Holdings
UWMC
+$3.15M
4
FSK icon
FS KKR Capital
FSK
+$2.88M
5
PCTY icon
Paylocity
PCTY
+$2.47M

Sector Composition

Rank Sector Weight
1 Industrials 17.65%
2 Technology 15.98%
3 Consumer Discretionary 15.36%
4 Healthcare 14.48%
5 Financials 11.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
QDEL icon
176
QuidelOrtho
QDEL
$612M
$421K 0.21%
+39,952
New +$586K
2026 Q3
0 quarters
BLFS icon
177
DELISTED
BioLife Solutions
BLFS
$418K 0.2%
+10,762
New +$364K
2026 Q3
0 quarters
CYTK icon
178
Cytokinetics
CYTK
$7.17B
$418K 0.2%
+6,338
New +$483K
2026 Q3
0 quarters
PII icon
179
Polaris
PII
$3.67B
$417K 0.2%
8,001
-3,105
-28% -$200K
2026 Q2
1 quarter
IRON icon
180
Disc Medicine
IRON
$3.47B
$416K 0.2%
+6,359
New +$481K
2026 Q3
0 quarters
CNMD icon
181
CONMED
CNMD
$1.38B
$416K 0.2%
+8,989
New +$412K
2026 Q3
0 quarters
IBRX icon
182
ImmunityBio
IBRX
$6.99B
$414K 0.2%
43,830
+29,924
+215% +$239K
2026 Q2
1 quarter
BBIO icon
183
BridgeBio Pharma
BBIO
$15.2B
$414K 0.2%
6,285
+1,265
+25% +$98.5K
2026 Q2
1 quarter
UFCS icon
184
United Fire Group
UFCS
$1.28B
$413K 0.2%
+7,844
New +$417K
2026 Q3
0 quarters
ADAM icon
185
Adamas Trust
ADAM
$435M
$411K 0.2%
+52,822
New +$489K
2026 Q3
0 quarters
DXPE icon
186
DXP Enterprises
DXPE
$2.35B
$410K 0.2%
+2,264
New +$406K
2026 Q3
0 quarters
RYTM icon
187
Rhythm Pharmaceuticals
RYTM
$8.1B
$408K 0.2%
+4,288
New +$458K
2026 Q3
0 quarters
BIO icon
188
Bio-Rad Laboratories Class A
BIO
$9.9B
$406K 0.2%
+1,076
New +$376K
2026 Q3
0 quarters
H icon
189
Hyatt Hotels
H
$17.4B
$406K 0.2%
+2,559
New +$448K
2026 Q3
0 quarters
FLOC icon
190
Flowco Holdings
FLOC
$935M
$405K 0.2%
22,402
-29,755
-57% -$617K
2026 Q2
1 quarter
VYX icon
191
NCR Voyix
VYX
$1.29B
$404K 0.2%
59,077
-11,641
-16% -$93.9K
2026 Q2
1 quarter
CSV icon
192
Carriage Services
CSV
$469M
$403K 0.2%
12,927
+4,066
+46% +$144K
2026 Q2
1 quarter
MIRM icon
193
Mirum Pharmaceuticals
MIRM
$6.24B
$401K 0.2%
4,687
+1,667
+55% +$174K
2026 Q2
1 quarter
GHM icon
194
Graham Corp
GHM
$908M
$401K 0.2%
+4,641
New +$456K
2026 Q3
0 quarters
AXSM icon
195
Axsome Therapeutics
AXSM
$7.14B
$400K 0.2%
+2,172
New +$473K
2026 Q3
0 quarters
IRWD icon
196
Ironwood Pharmaceuticals
IRWD
$780M
$397K 0.19%
+100,120
New +$418K
2026 Q3
0 quarters
NCLH icon
197
Norwegian Cruise Line
NCLH
$7.84B
$396K 0.19%
27,031
+6,895
+34% +$121K
2026 Q2
1 quarter
ENOV icon
198
Enovis
ENOV
$1.51B
$395K 0.19%
+21,611
New +$514K
2026 Q3
0 quarters
MFIC icon
199
MidCap Financial Investment
MFIC
$816M
$395K 0.19%
45,142
-24,050
-35% -$229K
2025 Q4
3 quarters
UCTT icon
200
Ultra Clean Holdings
UCTT
$2.04B
$386K 0.19%
+4,763
New +$397K
2026 Q3
0 quarters

Similar funds

VarCov Co's Q3 2026 Portfolio in Review

As of Q3 2026, VarCov Co held 574 positions worth $205M, down 22% from $263M the previous quarter. Its ten largest holdings account for 12% of the portfolio.

VarCov Co withdrew a net $43M in Q3 2026, closing 229 positions and reducing 71 holdings. Its most notable exit was CarMax, an estimated $3.97M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 18% of assets, up from 15% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, VarCov Co opened a new position in Amentum Holdings worth $2.71M.

  • VarCov Co's largest Q3 2026 buy was Amentum Holdings: 149,785 shares worth $2.71M.
  • VarCov Co added most to Bath & Body Works in Q3 2026, an estimated $1.37M increase.
  • VarCov Co's biggest Q3 2026 reduction was Paylocity, cutting an estimated $2.47M.
  • VarCov Co fully exited CarMax in Q3 2026, selling an estimated $3.97M.
  • VarCov Co's ten largest holdings make up 12% of its $205M portfolio in Q3 2026.
  • VarCov Co opened 222 new positions and closed 229 in Q3 2026.
  • VarCov Co's portfolio value fell 22% quarter-over-quarter to $205M.

Based on VarCov Co's 13F filing for Q3 2026, filed 16 Nov 2026.